C21H22N4O6S
458.5 g/mol
APIWarning
Raltitrexed
CAS112887-68-0
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Raltitrexed is an antimetabolite compound that acts as an inhibitor of thymidylate synthase. It is primarily used as an active pharmaceutical ingredient in chemotherapy manufacturing.
pharmaceutical manufacturingchemotherapy compound
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 112887-68-0
Related Compounds
ReferenceSame Category
Amifostine trihydrate
CAS112901-68-5
pharmaceutical raw material
ReferenceSame Category
Paclitaxel D5
CAS1129540-33-5
pharmaceutical raw material
ReferenceSame Category
Calcipotriene
CAS112965-21-6
pharmaceutical raw material
ReferenceSame Category
Ulifloxacin
CAS112984-60-8
pharmaceutical raw material
Safety Reference
Warning
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid
InChIKey
IVTVGDXNLFLDRM-HNNXBMFYSA-N
SMILES
CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N1
Synonyms (27)
- D-1694
- D16
- Raltitrexed (JAN/USAN/INN)
- 1hvy
- 1i00
- 2kce
- 2tsr
- ICI D1694
- RALTITREXED [MART.]
- Raltitrexed
- Raltitrexed (Tomudex)
- ZD1694; Raltitrexed
- raltitrexedum